Having been a symbol of quality and trust in the pharmaceutical industry, strictly based on the principles of sincerity, respect and trust, and being committed to its vision, mission and values; Dem İlaç has been established by the pharmaceutical professionals who have been serving in this industry since 1970, and has been serving Turkish Medicine with its effective production rate and rapid results, and increasing its quality and services since 1992.
Dem İlaç is a substantial member of the pharmaceutical industry with its licensed and imported medicines and medical preparations. It is responsible for the distribution of medicines throughout Türkiye along with Türkiye's major pharmaceutical warehouses.
Dem İlaç's portfolio encompass a range of pharmaceutical products, such as blood-related medications, anesthetic agents, plasma expanding solutions, antibiotics, biotechnology and biosimilar products sourced from renowned global producers, and licensed human pharmaceutical produced in state-of-the-art facilities in Türkiye.
With an intensified focus on product exploration and substantial investments in this industry, Dem İlaç has over 100 licensing agreements for human pharmaceuticals, blood-related products, and oncology medications.
Dem İlaç remains committed to its global research and pursuit of new product agreements, actively seeking new licensing agreements with partners to broaden its product portfolio, alongside the products it currently markets and products undergoing licensing processes.
Dem İlaç is making confident progress thanks to its vibrant, innovative, well-equipped staff who value collaboration, possess strong motivations, and are open to new ideas and advancements.
Türkiye's National Anchor in the Health Sector
Dem İlaç, which works and produces for public health with the vision of "Turkey's National Anchor in the Health Sector", today exports to 25 countries in 6 regions, especially Canada, Poland, Thailand, UAE, Latvia and Peru.
- Kanada- Dominik Cumhuriyeti- Peru